Global Analgesic and Anti-inflammatory API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Analgesic and Anti-inflammatory API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
This report is a detailed and comprehensive analysis for global Analgesic and Anti-inflammatory API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Analgesic and Anti-inflammatory API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Analgesic and Anti-inflammatory API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Analgesic and Anti-inflammatory API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Analgesic and Anti-inflammatory API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Analgesic and Anti-inflammatory API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Analgesic and Anti-inflammatory API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl and BASF, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Analgesic and Anti-inflammatory API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Analgesic and Anti-inflammatory API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Analgesic and Anti-inflammatory API, with price, sales, revenue and global market share of Analgesic and Anti-inflammatory API from 2018 to 2023.
Chapter 3, the Analgesic and Anti-inflammatory API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Analgesic and Anti-inflammatory API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Analgesic and Anti-inflammatory API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Analgesic and Anti-inflammatory API.
Chapter 14 and 15, to describe Analgesic and Anti-inflammatory API sales channel, distributors, customers, research findings and conclusion.
Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
This report is a detailed and comprehensive analysis for global Analgesic and Anti-inflammatory API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Analgesic and Anti-inflammatory API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Analgesic and Anti-inflammatory API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Analgesic and Anti-inflammatory API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Analgesic and Anti-inflammatory API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Analgesic and Anti-inflammatory API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Analgesic and Anti-inflammatory API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl and BASF, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Analgesic and Anti-inflammatory API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Ibuprofen
- Paracetamol
- Aspirin
- Naproxen
- Diclofenac
- Oxaprozin
- Dexibuprofen
- Others
- Adults
- Children
- IOL
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical
- Novacyl
- BASF
- BBCA Group
- Hubei Biocause Group
- Xinhua Pharm
- Granules India Limited
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Hunan Zhongnan Pharmaceutical
- Hebei Jingye Medical Technology
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Analgesic and Anti-inflammatory API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Analgesic and Anti-inflammatory API, with price, sales, revenue and global market share of Analgesic and Anti-inflammatory API from 2018 to 2023.
Chapter 3, the Analgesic and Anti-inflammatory API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Analgesic and Anti-inflammatory API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Analgesic and Anti-inflammatory API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Analgesic and Anti-inflammatory API.
Chapter 14 and 15, to describe Analgesic and Anti-inflammatory API sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Analgesic and Anti-inflammatory API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Analgesic and Anti-inflammatory API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Ibuprofen
1.3.3 Paracetamol
1.3.4 Aspirin
1.3.5 Naproxen
1.3.6 Diclofenac
1.3.7 Oxaprozin
1.3.8 Dexibuprofen
1.3.9 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Analgesic and Anti-inflammatory API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Analgesic and Anti-inflammatory API Market Size & Forecast
1.5.1 Global Analgesic and Anti-inflammatory API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Analgesic and Anti-inflammatory API Sales Quantity (2018-2029)
1.5.3 Global Analgesic and Anti-inflammatory API Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 IOL
2.1.1 IOL Details
2.1.2 IOL Major Business
2.1.3 IOL Analgesic and Anti-inflammatory API Product and Services
2.1.4 IOL Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IOL Recent Developments/Updates
2.2 Mallinckrodt Pharmaceuticals
2.2.1 Mallinckrodt Pharmaceuticals Details
2.2.2 Mallinckrodt Pharmaceuticals Major Business
2.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product and Services
2.2.4 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.3 Anqiu Lu'an Pharmaceutical
2.3.1 Anqiu Lu'an Pharmaceutical Details
2.3.2 Anqiu Lu'an Pharmaceutical Major Business
2.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.3.4 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
2.4 Novacyl
2.4.1 Novacyl Details
2.4.2 Novacyl Major Business
2.4.3 Novacyl Analgesic and Anti-inflammatory API Product and Services
2.4.4 Novacyl Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novacyl Recent Developments/Updates
2.5 BASF
2.5.1 BASF Details
2.5.2 BASF Major Business
2.5.3 BASF Analgesic and Anti-inflammatory API Product and Services
2.5.4 BASF Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BASF Recent Developments/Updates
2.6 BBCA Group
2.6.1 BBCA Group Details
2.6.2 BBCA Group Major Business
2.6.3 BBCA Group Analgesic and Anti-inflammatory API Product and Services
2.6.4 BBCA Group Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BBCA Group Recent Developments/Updates
2.7 Hubei Biocause Group
2.7.1 Hubei Biocause Group Details
2.7.2 Hubei Biocause Group Major Business
2.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Product and Services
2.7.4 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hubei Biocause Group Recent Developments/Updates
2.8 Xinhua Pharm
2.8.1 Xinhua Pharm Details
2.8.2 Xinhua Pharm Major Business
2.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Product and Services
2.8.4 Xinhua Pharm Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Xinhua Pharm Recent Developments/Updates
2.9 Granules India Limited
2.9.1 Granules India Limited Details
2.9.2 Granules India Limited Major Business
2.9.3 Granules India Limited Analgesic and Anti-inflammatory API Product and Services
2.9.4 Granules India Limited Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Granules India Limited Recent Developments/Updates
2.10 Hebei Jiheng Pharmaceutical
2.10.1 Hebei Jiheng Pharmaceutical Details
2.10.2 Hebei Jiheng Pharmaceutical Major Business
2.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.10.4 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
2.11 Zhejiang Kangle Pharmaceutical
2.11.1 Zhejiang Kangle Pharmaceutical Details
2.11.2 Zhejiang Kangle Pharmaceutical Major Business
2.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.11.4 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
2.12 Hunan Zhongnan Pharmaceutical
2.12.1 Hunan Zhongnan Pharmaceutical Details
2.12.2 Hunan Zhongnan Pharmaceutical Major Business
2.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.12.4 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
2.13 Hebei Jingye Medical Technology
2.13.1 Hebei Jingye Medical Technology Details
2.13.2 Hebei Jingye Medical Technology Major Business
2.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product and Services
2.13.4 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANALGESIC AND ANTI-INFLAMMATORY API BY MANUFACTURER
3.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Analgesic and Anti-inflammatory API Revenue by Manufacturer (2018-2023)
3.3 Global Analgesic and Anti-inflammatory API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Analgesic and Anti-inflammatory API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Analgesic and Anti-inflammatory API Manufacturer Market Share in 2022
3.4.2 Top 6 Analgesic and Anti-inflammatory API Manufacturer Market Share in 2022
3.5 Analgesic and Anti-inflammatory API Market: Overall Company Footprint Analysis
3.5.1 Analgesic and Anti-inflammatory API Market: Region Footprint
3.5.2 Analgesic and Anti-inflammatory API Market: Company Product Type Footprint
3.5.3 Analgesic and Anti-inflammatory API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Analgesic and Anti-inflammatory API Market Size by Region
4.1.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2029)
4.1.2 Global Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2029)
4.1.3 Global Analgesic and Anti-inflammatory API Average Price by Region (2018-2029)
4.2 North America Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.3 Europe Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.4 Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.5 South America Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.6 Middle East and Africa Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
5.2 Global Analgesic and Anti-inflammatory API Consumption Value by Type (2018-2029)
5.3 Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
6.2 Global Analgesic and Anti-inflammatory API Consumption Value by Application (2018-2029)
6.3 Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
7.2 North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
7.3 North America Analgesic and Anti-inflammatory API Market Size by Country
7.3.1 North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
7.3.2 North America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
8.2 Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
8.3 Europe Analgesic and Anti-inflammatory API Market Size by Country
8.3.1 Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
8.3.2 Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Analgesic and Anti-inflammatory API Market Size by Region
9.3.1 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
10.2 South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
10.3 South America Analgesic and Anti-inflammatory API Market Size by Country
10.3.1 South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
10.3.2 South America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Analgesic and Anti-inflammatory API Market Size by Country
11.3.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Analgesic and Anti-inflammatory API Market Drivers
12.2 Analgesic and Anti-inflammatory API Market Restraints
12.3 Analgesic and Anti-inflammatory API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Analgesic and Anti-inflammatory API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Analgesic and Anti-inflammatory API
13.3 Analgesic and Anti-inflammatory API Production Process
13.4 Analgesic and Anti-inflammatory API Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Analgesic and Anti-inflammatory API Typical Distributors
14.3 Analgesic and Anti-inflammatory API Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Analgesic and Anti-inflammatory API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Analgesic and Anti-inflammatory API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Ibuprofen
1.3.3 Paracetamol
1.3.4 Aspirin
1.3.5 Naproxen
1.3.6 Diclofenac
1.3.7 Oxaprozin
1.3.8 Dexibuprofen
1.3.9 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Analgesic and Anti-inflammatory API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Analgesic and Anti-inflammatory API Market Size & Forecast
1.5.1 Global Analgesic and Anti-inflammatory API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Analgesic and Anti-inflammatory API Sales Quantity (2018-2029)
1.5.3 Global Analgesic and Anti-inflammatory API Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 IOL
2.1.1 IOL Details
2.1.2 IOL Major Business
2.1.3 IOL Analgesic and Anti-inflammatory API Product and Services
2.1.4 IOL Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IOL Recent Developments/Updates
2.2 Mallinckrodt Pharmaceuticals
2.2.1 Mallinckrodt Pharmaceuticals Details
2.2.2 Mallinckrodt Pharmaceuticals Major Business
2.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product and Services
2.2.4 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.3 Anqiu Lu'an Pharmaceutical
2.3.1 Anqiu Lu'an Pharmaceutical Details
2.3.2 Anqiu Lu'an Pharmaceutical Major Business
2.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.3.4 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
2.4 Novacyl
2.4.1 Novacyl Details
2.4.2 Novacyl Major Business
2.4.3 Novacyl Analgesic and Anti-inflammatory API Product and Services
2.4.4 Novacyl Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novacyl Recent Developments/Updates
2.5 BASF
2.5.1 BASF Details
2.5.2 BASF Major Business
2.5.3 BASF Analgesic and Anti-inflammatory API Product and Services
2.5.4 BASF Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BASF Recent Developments/Updates
2.6 BBCA Group
2.6.1 BBCA Group Details
2.6.2 BBCA Group Major Business
2.6.3 BBCA Group Analgesic and Anti-inflammatory API Product and Services
2.6.4 BBCA Group Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BBCA Group Recent Developments/Updates
2.7 Hubei Biocause Group
2.7.1 Hubei Biocause Group Details
2.7.2 Hubei Biocause Group Major Business
2.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Product and Services
2.7.4 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hubei Biocause Group Recent Developments/Updates
2.8 Xinhua Pharm
2.8.1 Xinhua Pharm Details
2.8.2 Xinhua Pharm Major Business
2.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Product and Services
2.8.4 Xinhua Pharm Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Xinhua Pharm Recent Developments/Updates
2.9 Granules India Limited
2.9.1 Granules India Limited Details
2.9.2 Granules India Limited Major Business
2.9.3 Granules India Limited Analgesic and Anti-inflammatory API Product and Services
2.9.4 Granules India Limited Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Granules India Limited Recent Developments/Updates
2.10 Hebei Jiheng Pharmaceutical
2.10.1 Hebei Jiheng Pharmaceutical Details
2.10.2 Hebei Jiheng Pharmaceutical Major Business
2.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.10.4 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
2.11 Zhejiang Kangle Pharmaceutical
2.11.1 Zhejiang Kangle Pharmaceutical Details
2.11.2 Zhejiang Kangle Pharmaceutical Major Business
2.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.11.4 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
2.12 Hunan Zhongnan Pharmaceutical
2.12.1 Hunan Zhongnan Pharmaceutical Details
2.12.2 Hunan Zhongnan Pharmaceutical Major Business
2.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
2.12.4 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
2.13 Hebei Jingye Medical Technology
2.13.1 Hebei Jingye Medical Technology Details
2.13.2 Hebei Jingye Medical Technology Major Business
2.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product and Services
2.13.4 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANALGESIC AND ANTI-INFLAMMATORY API BY MANUFACTURER
3.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Analgesic and Anti-inflammatory API Revenue by Manufacturer (2018-2023)
3.3 Global Analgesic and Anti-inflammatory API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Analgesic and Anti-inflammatory API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Analgesic and Anti-inflammatory API Manufacturer Market Share in 2022
3.4.2 Top 6 Analgesic and Anti-inflammatory API Manufacturer Market Share in 2022
3.5 Analgesic and Anti-inflammatory API Market: Overall Company Footprint Analysis
3.5.1 Analgesic and Anti-inflammatory API Market: Region Footprint
3.5.2 Analgesic and Anti-inflammatory API Market: Company Product Type Footprint
3.5.3 Analgesic and Anti-inflammatory API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Analgesic and Anti-inflammatory API Market Size by Region
4.1.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2029)
4.1.2 Global Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2029)
4.1.3 Global Analgesic and Anti-inflammatory API Average Price by Region (2018-2029)
4.2 North America Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.3 Europe Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.4 Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.5 South America Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
4.6 Middle East and Africa Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
5.2 Global Analgesic and Anti-inflammatory API Consumption Value by Type (2018-2029)
5.3 Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
6.2 Global Analgesic and Anti-inflammatory API Consumption Value by Application (2018-2029)
6.3 Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
7.2 North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
7.3 North America Analgesic and Anti-inflammatory API Market Size by Country
7.3.1 North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
7.3.2 North America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
8.2 Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
8.3 Europe Analgesic and Anti-inflammatory API Market Size by Country
8.3.1 Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
8.3.2 Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Analgesic and Anti-inflammatory API Market Size by Region
9.3.1 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
10.2 South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
10.3 South America Analgesic and Anti-inflammatory API Market Size by Country
10.3.1 South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
10.3.2 South America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Analgesic and Anti-inflammatory API Market Size by Country
11.3.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Analgesic and Anti-inflammatory API Market Drivers
12.2 Analgesic and Anti-inflammatory API Market Restraints
12.3 Analgesic and Anti-inflammatory API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Analgesic and Anti-inflammatory API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Analgesic and Anti-inflammatory API
13.3 Analgesic and Anti-inflammatory API Production Process
13.4 Analgesic and Anti-inflammatory API Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Analgesic and Anti-inflammatory API Typical Distributors
14.3 Analgesic and Anti-inflammatory API Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Analgesic and Anti-inflammatory API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Analgesic and Anti-inflammatory API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. IOL Basic Information, Manufacturing Base and Competitors
Table 4. IOL Major Business
Table 5. IOL Analgesic and Anti-inflammatory API Product and Services
Table 6. IOL Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. IOL Recent Developments/Updates
Table 8. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Mallinckrodt Pharmaceuticals Major Business
Table 10. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product and Services
Table 11. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 13. Anqiu Lu'an Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Anqiu Lu'an Pharmaceutical Major Business
Table 15. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 16. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
Table 18. Novacyl Basic Information, Manufacturing Base and Competitors
Table 19. Novacyl Major Business
Table 20. Novacyl Analgesic and Anti-inflammatory API Product and Services
Table 21. Novacyl Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novacyl Recent Developments/Updates
Table 23. BASF Basic Information, Manufacturing Base and Competitors
Table 24. BASF Major Business
Table 25. BASF Analgesic and Anti-inflammatory API Product and Services
Table 26. BASF Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. BASF Recent Developments/Updates
Table 28. BBCA Group Basic Information, Manufacturing Base and Competitors
Table 29. BBCA Group Major Business
Table 30. BBCA Group Analgesic and Anti-inflammatory API Product and Services
Table 31. BBCA Group Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. BBCA Group Recent Developments/Updates
Table 33. Hubei Biocause Group Basic Information, Manufacturing Base and Competitors
Table 34. Hubei Biocause Group Major Business
Table 35. Hubei Biocause Group Analgesic and Anti-inflammatory API Product and Services
Table 36. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hubei Biocause Group Recent Developments/Updates
Table 38. Xinhua Pharm Basic Information, Manufacturing Base and Competitors
Table 39. Xinhua Pharm Major Business
Table 40. Xinhua Pharm Analgesic and Anti-inflammatory API Product and Services
Table 41. Xinhua Pharm Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Xinhua Pharm Recent Developments/Updates
Table 43. Granules India Limited Basic Information, Manufacturing Base and Competitors
Table 44. Granules India Limited Major Business
Table 45. Granules India Limited Analgesic and Anti-inflammatory API Product and Services
Table 46. Granules India Limited Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Granules India Limited Recent Developments/Updates
Table 48. Hebei Jiheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Hebei Jiheng Pharmaceutical Major Business
Table 50. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 51. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hebei Jiheng Pharmaceutical Recent Developments/Updates
Table 53. Zhejiang Kangle Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Kangle Pharmaceutical Major Business
Table 55. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 56. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
Table 58. Hunan Zhongnan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Hunan Zhongnan Pharmaceutical Major Business
Table 60. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 61. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hunan Zhongnan Pharmaceutical Recent Developments/Updates
Table 63. Hebei Jingye Medical Technology Basic Information, Manufacturing Base and Competitors
Table 64. Hebei Jingye Medical Technology Major Business
Table 65. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product and Services
Table 66. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hebei Jingye Medical Technology Recent Developments/Updates
Table 68. Global Analgesic and Anti-inflammatory API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 69. Global Analgesic and Anti-inflammatory API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Analgesic and Anti-inflammatory API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 71. Market Position of Manufacturers in Analgesic and Anti-inflammatory API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Analgesic and Anti-inflammatory API Production Site of Key Manufacturer
Table 73. Analgesic and Anti-inflammatory API Market: Company Product Type Footprint
Table 74. Analgesic and Anti-inflammatory API Market: Company Product Application Footprint
Table 75. Analgesic and Anti-inflammatory API New Market Entrants and Barriers to Market Entry
Table 76. Analgesic and Anti-inflammatory API Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2023) & (Tons)
Table 78. Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2024-2029) & (Tons)
Table 79. Global Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Analgesic and Anti-inflammatory API Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Analgesic and Anti-inflammatory API Average Price by Region (2018-2023) & (US$/Ton)
Table 82. Global Analgesic and Anti-inflammatory API Average Price by Region (2024-2029) & (US$/Ton)
Table 83. Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Global Analgesic and Anti-inflammatory API Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Analgesic and Anti-inflammatory API Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2023) & (US$/Ton)
Table 88. Global Analgesic and Anti-inflammatory API Average Price by Type (2024-2029) & (US$/Ton)
Table 89. Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 90. Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 91. Global Analgesic and Anti-inflammatory API Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Analgesic and Anti-inflammatory API Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2023) & (US$/Ton)
Table 94. Global Analgesic and Anti-inflammatory API Average Price by Application (2024-2029) & (US$/Ton)
Table 95. North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 96. North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 97. North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 98. North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 99. North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2023) & (Tons)
Table 100. North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2024-2029) & (Tons)
Table 101. North America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Analgesic and Anti-inflammatory API Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 104. Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 105. Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 106. Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 107. Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2023) & (Tons)
Table 108. Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2024-2029) & (Tons)
Table 109. Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 112. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 113. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 114. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 115. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2023) & (Tons)
Table 116. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2024-2029) & (Tons)
Table 117. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 120. South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 121. South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 122. South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 123. South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2023) & (Tons)
Table 124. South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2024-2029) & (Tons)
Table 125. South America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Analgesic and Anti-inflammatory API Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 128. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 129. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 130. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 131. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2023) & (Tons)
Table 132. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Region (2024-2029) & (Tons)
Table 133. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Analgesic and Anti-inflammatory API Raw Material
Table 136. Key Manufacturers of Analgesic and Anti-inflammatory API Raw Materials
Table 137. Analgesic and Anti-inflammatory API Typical Distributors
Table 138. Analgesic and Anti-inflammatory API Typical Customers
Table 1. Global Analgesic and Anti-inflammatory API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Analgesic and Anti-inflammatory API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. IOL Basic Information, Manufacturing Base and Competitors
Table 4. IOL Major Business
Table 5. IOL Analgesic and Anti-inflammatory API Product and Services
Table 6. IOL Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. IOL Recent Developments/Updates
Table 8. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Mallinckrodt Pharmaceuticals Major Business
Table 10. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product and Services
Table 11. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 13. Anqiu Lu'an Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Anqiu Lu'an Pharmaceutical Major Business
Table 15. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 16. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
Table 18. Novacyl Basic Information, Manufacturing Base and Competitors
Table 19. Novacyl Major Business
Table 20. Novacyl Analgesic and Anti-inflammatory API Product and Services
Table 21. Novacyl Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novacyl Recent Developments/Updates
Table 23. BASF Basic Information, Manufacturing Base and Competitors
Table 24. BASF Major Business
Table 25. BASF Analgesic and Anti-inflammatory API Product and Services
Table 26. BASF Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. BASF Recent Developments/Updates
Table 28. BBCA Group Basic Information, Manufacturing Base and Competitors
Table 29. BBCA Group Major Business
Table 30. BBCA Group Analgesic and Anti-inflammatory API Product and Services
Table 31. BBCA Group Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. BBCA Group Recent Developments/Updates
Table 33. Hubei Biocause Group Basic Information, Manufacturing Base and Competitors
Table 34. Hubei Biocause Group Major Business
Table 35. Hubei Biocause Group Analgesic and Anti-inflammatory API Product and Services
Table 36. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hubei Biocause Group Recent Developments/Updates
Table 38. Xinhua Pharm Basic Information, Manufacturing Base and Competitors
Table 39. Xinhua Pharm Major Business
Table 40. Xinhua Pharm Analgesic and Anti-inflammatory API Product and Services
Table 41. Xinhua Pharm Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Xinhua Pharm Recent Developments/Updates
Table 43. Granules India Limited Basic Information, Manufacturing Base and Competitors
Table 44. Granules India Limited Major Business
Table 45. Granules India Limited Analgesic and Anti-inflammatory API Product and Services
Table 46. Granules India Limited Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Granules India Limited Recent Developments/Updates
Table 48. Hebei Jiheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Hebei Jiheng Pharmaceutical Major Business
Table 50. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 51. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hebei Jiheng Pharmaceutical Recent Developments/Updates
Table 53. Zhejiang Kangle Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Kangle Pharmaceutical Major Business
Table 55. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 56. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
Table 58. Hunan Zhongnan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Hunan Zhongnan Pharmaceutical Major Business
Table 60. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
Table 61. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hunan Zhongnan Pharmaceutical Recent Developments/Updates
Table 63. Hebei Jingye Medical Technology Basic Information, Manufacturing Base and Competitors
Table 64. Hebei Jingye Medical Technology Major Business
Table 65. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product and Services
Table 66. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hebei Jingye Medical Technology Recent Developments/Updates
Table 68. Global Analgesic and Anti-inflammatory API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 69. Global Analgesic and Anti-inflammatory API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Analgesic and Anti-inflammatory API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 71. Market Position of Manufacturers in Analgesic and Anti-inflammatory API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Analgesic and Anti-inflammatory API Production Site of Key Manufacturer
Table 73. Analgesic and Anti-inflammatory API Market: Company Product Type Footprint
Table 74. Analgesic and Anti-inflammatory API Market: Company Product Application Footprint
Table 75. Analgesic and Anti-inflammatory API New Market Entrants and Barriers to Market Entry
Table 76. Analgesic and Anti-inflammatory API Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2023) & (Tons)
Table 78. Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2024-2029) & (Tons)
Table 79. Global Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Analgesic and Anti-inflammatory API Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Analgesic and Anti-inflammatory API Average Price by Region (2018-2023) & (US$/Ton)
Table 82. Global Analgesic and Anti-inflammatory API Average Price by Region (2024-2029) & (US$/Ton)
Table 83. Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Global Analgesic and Anti-inflammatory API Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Analgesic and Anti-inflammatory API Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2023) & (US$/Ton)
Table 88. Global Analgesic and Anti-inflammatory API Average Price by Type (2024-2029) & (US$/Ton)
Table 89. Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 90. Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 91. Global Analgesic and Anti-inflammatory API Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Analgesic and Anti-inflammatory API Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2023) & (US$/Ton)
Table 94. Global Analgesic and Anti-inflammatory API Average Price by Application (2024-2029) & (US$/Ton)
Table 95. North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 96. North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 97. North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 98. North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 99. North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2023) & (Tons)
Table 100. North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2024-2029) & (Tons)
Table 101. North America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Analgesic and Anti-inflammatory API Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 104. Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 105. Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 106. Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 107. Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2023) & (Tons)
Table 108. Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2024-2029) & (Tons)
Table 109. Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 112. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 113. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 114. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 115. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2023) & (Tons)
Table 116. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2024-2029) & (Tons)
Table 117. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 120. South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 121. South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 122. South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 123. South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2023) & (Tons)
Table 124. South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2024-2029) & (Tons)
Table 125. South America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Analgesic and Anti-inflammatory API Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2023) & (Tons)
Table 128. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2024-2029) & (Tons)
Table 129. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2023) & (Tons)
Table 130. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2024-2029) & (Tons)
Table 131. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2023) & (Tons)
Table 132. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Region (2024-2029) & (Tons)
Table 133. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Analgesic and Anti-inflammatory API Raw Material
Table 136. Key Manufacturers of Analgesic and Anti-inflammatory API Raw Materials
Table 137. Analgesic and Anti-inflammatory API Typical Distributors
Table 138. Analgesic and Anti-inflammatory API Typical Customers
LIST OF FIGURES
Figure 1. Analgesic and Anti-inflammatory API Picture
Figure 2. Global Analgesic and Anti-inflammatory API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Type in 2022
Figure 4. Ibuprofen Examples
Figure 5. Paracetamol Examples
Figure 6. Aspirin Examples
Figure 7. Naproxen Examples
Figure 8. Diclofenac Examples
Figure 9. Oxaprozin Examples
Figure 10. Dexibuprofen Examples
Figure 11. Others Examples
Figure 12. Global Analgesic and Anti-inflammatory API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Application in 2022
Figure 14. Adults Examples
Figure 15. Children Examples
Figure 16. Global Analgesic and Anti-inflammatory API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Analgesic and Anti-inflammatory API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Analgesic and Anti-inflammatory API Sales Quantity (2018-2029) & (Tons)
Figure 19. Global Analgesic and Anti-inflammatory API Average Price (2018-2029) & (US$/Ton)
Figure 20. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Analgesic and Anti-inflammatory API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Analgesic and Anti-inflammatory API Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Analgesic and Anti-inflammatory API Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2029) & (US$/Ton)
Figure 35. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2029) & (US$/Ton)
Figure 38. North America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Analgesic and Anti-inflammatory API Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Analgesic and Anti-inflammatory API Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Analgesic and Anti-inflammatory API Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value Market Share by Region (2018-2029)
Figure 58. China Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Analgesic and Anti-inflammatory API Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Analgesic and Anti-inflammatory API Market Drivers
Figure 79. Analgesic and Anti-inflammatory API Market Restraints
Figure 80. Analgesic and Anti-inflammatory API Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Analgesic and Anti-inflammatory API in 2022
Figure 83. Manufacturing Process Analysis of Analgesic and Anti-inflammatory API
Figure 84. Analgesic and Anti-inflammatory API Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Analgesic and Anti-inflammatory API Picture
Figure 2. Global Analgesic and Anti-inflammatory API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Type in 2022
Figure 4. Ibuprofen Examples
Figure 5. Paracetamol Examples
Figure 6. Aspirin Examples
Figure 7. Naproxen Examples
Figure 8. Diclofenac Examples
Figure 9. Oxaprozin Examples
Figure 10. Dexibuprofen Examples
Figure 11. Others Examples
Figure 12. Global Analgesic and Anti-inflammatory API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Application in 2022
Figure 14. Adults Examples
Figure 15. Children Examples
Figure 16. Global Analgesic and Anti-inflammatory API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Analgesic and Anti-inflammatory API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Analgesic and Anti-inflammatory API Sales Quantity (2018-2029) & (Tons)
Figure 19. Global Analgesic and Anti-inflammatory API Average Price (2018-2029) & (US$/Ton)
Figure 20. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Analgesic and Anti-inflammatory API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Analgesic and Anti-inflammatory API Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Analgesic and Anti-inflammatory API Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2029) & (US$/Ton)
Figure 35. Global Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Analgesic and Anti-inflammatory API Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2029) & (US$/Ton)
Figure 38. North America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Analgesic and Anti-inflammatory API Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Analgesic and Anti-inflammatory API Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Analgesic and Anti-inflammatory API Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value Market Share by Region (2018-2029)
Figure 58. China Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Analgesic and Anti-inflammatory API Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Analgesic and Anti-inflammatory API Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Analgesic and Anti-inflammatory API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Analgesic and Anti-inflammatory API Market Drivers
Figure 79. Analgesic and Anti-inflammatory API Market Restraints
Figure 80. Analgesic and Anti-inflammatory API Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Analgesic and Anti-inflammatory API in 2022
Figure 83. Manufacturing Process Analysis of Analgesic and Anti-inflammatory API
Figure 84. Analgesic and Anti-inflammatory API Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
